{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T23:01:25Z","timestamp":1762383685169,"version":"build-2065373602"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"vor","delay-in-days":212,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02337","type":"journal-article","created":{"date-parts":[[2025,8,5]],"date-time":"2025-08-05T17:44:40Z","timestamp":1754415880000},"page":"e02337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Strongyloidiasis in a heart transplant recipient: Exploring the use of veterinary-formulated subcutaneous ivermectin and a review of the literature"],"prefix":"10.1016","volume":"41","author":[{"ORCID":"https:\/\/orcid.org\/0009-0008-4408-0360","authenticated-orcid":false,"given":"Rahma","family":"Aldhaheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caitlin A.","family":"Trottier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Treeva","family":"Jassim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoe Freeman","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2025.e02337_bib1","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ijid.2020.09.002","article-title":"Modeling strongyloidiasis risk in the United States","volume":"100","author":"Singer","year":"2020","journal-title":"Int J Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02337_sbref2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.3390\/tropicalmed3020053","article-title":"The unique life cycle of strongyloides stercoralis and implications for public health action","volume":"3","author":"Page","year":"2018","journal-title":"Trop Med Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02337_sbref3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11908-008-0019-6","article-title":"Strongyloides stercoralis infection in the immunocompromised host","volume":"10","author":"Ramanathan","year":"2008","journal-title":"Curr Infect Dis Rep"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02337_bib3","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1128\/CMR.17.1.208-217.2004","article-title":"Strongyloides stercoralis in the immunocompromised population","volume":"17","author":"Keiser","year":"2004","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02337_bib4","volume":"33","author":"La Hoz","year":"2019","journal-title":"Clin Transpl"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02337_bib5","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4269\/ajtmh.2010.09-0750","article-title":"Strongyloidiasis-related deaths in the United States, 1991\u20132006","volume":"83","author":"Croker","year":"2010","journal-title":"Am J Trop Med Hyg"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02337_bib6","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.tmaid.2016.10.011","article-title":"Strongyloidiasis in ontario: performance of diagnostic tests over a 14-month period","volume":"14","author":"Dong","year":"2016","journal-title":"Travel Med Infect Dis"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02337_bib7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.idc.2018.04.012","article-title":"Management of strongyloides in solid organ transplant recipients","volume":"32","author":"Hayes","year":"2018","journal-title":"Infect Dis Clin N Am"},{"issue":"11","key":"10.1016\/j.idcr.2025.e02337_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14795","article-title":"A comprehensive review of strongyloides stercoralis infection after solid organ and hematopoietic stem cell transplantation","volume":"36","author":"Abad","year":"2022","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02337_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.13497","article-title":"Implementation of a strongyloides screening strategy in solid organ transplant donors and recipients","volume":"33","author":"Camargo","year":"2019","journal-title":"Clin Transpl"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02337_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.clinme.2024.100227","article-title":"Strongyloides stercoralis infection in the UK: a systematic review and meta-analysis of published cases","volume":"24","author":"Alam","year":"2024","journal-title":"Clin Med"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02337_bib11","doi-asserted-by":"crossref","DOI":"10.1111\/tid.14059","article-title":"Investigation of donor-derived strongyloides stercoralis infection in multiple solid organ transplant recipients-California, Michigan, Ohio, 2022","volume":"25","author":"Adeyemo","year":"2023","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02337_bib12","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.832430","article-title":"Human T-cell lymphotropic virus type 1 and Strongyloides stercoralis co-infection: a systematic review and meta-analysis","volume":"9","author":"Ye","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/j.idcr.2025.e02337_bib13","unstructured":"Quest Diagnostics. Strongyloides antibody, IgG. Quest Diagnostics. \u3008https:\/\/testdirectory.questdiagnostics.com\/test\/test-detail\/34309\/strongyloides-antibody-igg?cc=MASTER\u3009."},{"issue":"1","key":"10.1016\/j.idcr.2025.e02337_bib14","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1093\/jac\/dkv315","article-title":"Subcutaneous ivermectin use in the treatment of severe strongyloides stercoralis infection: two case reports and a discussion of the literature","volume":"71","author":"Barrett","year":"2016","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.idcr.2025.e02337_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2017-223138","article-title":"Successful use of subcutaneous ivermectin for the treatment of strongyloides stercoralis hyperinfection in the setting of small bowel obstruction and paralytic ileus in the immunocompromised population","volume":"2018","author":"Zeitler","year":"2018","journal-title":"BMJ Case Rep"},{"issue":"6","key":"10.1016\/j.idcr.2025.e02337_bib16","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.4269\/ajtmh.18-0387","article-title":"Case report: subcutaneous ivermectin pharmacokinetics in disseminated strongyloides infection: plasma and postmortem analysis","volume":"99","author":"Konecny","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02337_bib17","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3390\/tropicalmed3020046","article-title":"strongyloides stercoralishyperinfection in an HIV-Infected patient successfully treated with subcutaneous ivermectin","volume":"3","author":"Grossi","year":"2018","journal-title":"Trop Med Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02337_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4269\/ajtmh.18-0487","article-title":"Case report: ivermectin and albendazole plasma concentrations in a patient with disseminated strongyloidiasis on extracorporeal membrane oxygenation and continuous renal replacement therapy","volume":"99","author":"Boodman","year":"2018","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02337_bib19","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.transproceed.2018.02.019","article-title":"Successful treatment of strongyloides stercoralis hyperinfection in a kidney transplant recipient: case report","volume":"50","author":"Rego Silva","year":"2018","journal-title":"Transpl Proc"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02337_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13008","article-title":"Donor-derived strongyloidiasis after organ transplantation in Norway","volume":"21","author":"Nordheim","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02337_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ijid.2019.06.026","article-title":"Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin","volume":"86","author":"Balkhair","year":"2019","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.idcr.2025.e02337_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2020.e00703","article-title":"Donor-derived fatal hyperinfection strongyloidiasis in renal transplant recipient","volume":"19","author":"Cipriano","year":"2020","journal-title":"IDCases"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925001933?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250925001933?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T22:58:38Z","timestamp":1762383518000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250925001933"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":23,"alternative-id":["S2214250925001933"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02337","relation":{},"ISSN":["2214-2509"],"issn-type":[{"type":"print","value":"2214-2509"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strongyloidiasis in a heart transplant recipient: Exploring the use of veterinary-formulated subcutaneous ivermectin and a review of the literature","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02337","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02337"}}